Rare Disease Day is celebrated globally in February, coinciding with the rarest day of the year, February 29. A rare disease is defined as one that affects fewer than one in every 2,000 people. Over 8,000 rare diseases have been documented worldwide, but unfortunately, only 5% have an effective treatment available. The prevale...
Each of us carries at least one gene that causes a genetic disease. Carriers are usually healthy but have a significant risk of passing the severe genetic disease on to their children. Without the GeneScreen Complete test, these diseases may go undetected, potentially leading to health issues in the child.
...
The SMART test is an innovative and modern first trimester combined screening. It combines the strengths of two different non-invasive fetal extracellular DNA tests with the advantages of two high-tech ultrasound examinations of the fetus at different stages of development.
SMART test, a very early ultrasound examination...
The GeneSafe Complete test is a prenatal non-invasive screening test that can be used to detect 29 fetal gene mutations that can cause 49 different gene diseases that are often undetectable by ultrasound and often manifest only in late pregnancy or during the first years of a child's life
February marks International Prenatal Infection Prevention Month, a global initiative to raise awareness of mother-to-child transmission.
How does the infection reach the uterus?
Pathogens or microbes are usually spread by direct contact with the bodily fluids of an infected person or p...
The ultrasound examination of fetal developmental defects is one of the most important ultrasound examinations during pregnancy. This examination is performed using abdominal transducers on weeks 19 to 21 +6 of the pregnancy. In this size of pregnancy, the fetus has developed all organs and begins its period of growth and maturation. At the 20...
